Precision 're'arming of CD33 antibodies

被引:1
|
作者
Borthakur, Gautam [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
CELLS;
D O I
10.1182/blood-2013-06-509638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1334 / 1334
页数:1
相关论文
共 50 条
  • [21] CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing
    Malik, Manasi
    Simpson, James F.
    Parikh, Ishita
    Wilfred, Bernard R.
    Fardo, David W.
    Nelson, Peter T.
    Estus, Steven
    JOURNAL OF NEUROSCIENCE, 2013, 33 (33): : 13320 - 13325
  • [22] CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients
    Lamba, Jatinder K.
    Voigt, Andrew P.
    Chauhan, Lata
    Shin, Miyoung
    Aplenc, Richard
    Brodersen, Lisa Eidenschink
    Gamis, Alan S.
    Meshinchi, Soheil
    Loken, Michael R.
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2250 - 2253
  • [23] CD33 BiTE: From Molecule to Therapy
    Subklewe, Marion
    ANNALS OF HEMATOLOGY, 2019, 98 : S69 - S70
  • [24] Effect of APOE and CD33 on Cognitive Decline
    Hayden, Kathleen M.
    Lutz, Michael W.
    Kuchibhatla, Maragatha
    Germain, Cassandra
    Plassman, Brenda L.
    PLOS ONE, 2015, 10 (06):
  • [25] Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330
    Laszlo, George S.
    Beddoe, Mary E.
    Godwin, Colin D.
    Bates, Olivia M.
    Gudgeon, Chelsea J.
    Harrington, Kimberly H.
    Walter, Roland B.
    HAEMATOLOGICA, 2019, 104 (02) : E59 - E62
  • [26] Evaluation Of CD33 Expression and Functional Analysis Of The CD33/CD3 Bispecific BiTE® Antibody AMG 330 In Primary AML Samples
    Krupka, Christina
    Kufer, Peter
    Kischel, Roman
    Zugmaier, Gerhard
    Boegeholz, Jan
    Koehnke, Thomas
    Lichtenegger, Felix S.
    Schneider, Stephanie
    Metzeler, Klaus H.
    Fiegl, Michael
    Spiekermann, Karsten
    Baeuerle, Patrick
    Hiddemann, Wolfgang
    Riethmueller, Gert
    Subklewe, Marion
    BLOOD, 2013, 122 (21)
  • [27] IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
    Karim Shamsasenjan
    Ken-ichiro Otsuyama
    Saeid Abroun
    Mohd S. Iqbal
    Maged S. Mahmoud
    Hideki Asaoku
    Michio M. Kawano
    International Journal of Hematology, 2009, 89 : 310 - 318
  • [28] IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
    Shamsasenjan, Karim
    Otsuyama, Ken-ichiro
    Abroun, Saeid
    Iqbal, Mohd S.
    Mahmoud, Maged S.
    Asaoku, Hideki
    Kawano, Michio M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 310 - 318
  • [29] Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
    Walke, Douglas G.
    Whetzel, Alexis M.
    Serrano, Geidy
    Sue, Lucia I.
    Beach, Thomas G.
    Lue, Lih-Fen
    NEUROBIOLOGY OF AGING, 2015, 36 (02) : 571 - 582
  • [30] Targeting CD33 for acute myeloid leukemia therapy
    Liu, Jingjing
    Tong, Jiayin
    Yang, Haiping
    BMC CANCER, 2022, 22 (01)